Perhaps the most characterized of these is the activation of the tyrosine kinase cellular Abelson tyrosine kinase (c-Abl) associated with the Philadelphia chromosome fusion event in chronic myeloid leukemia (CML) [28]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.